Patients with advanced-stage disease had significantly higher median percentage of PD-L1+ monocytes in both peripheral blood (81.8 vs. 34.4%, P = 0.007) and tumor tissues (39.1 vs. 11.1%, P < 0.001), compared with those with early-stage disease. Here, CD274 is linked to neoplasm.